Oticon Intent vs Otofonix Encore

The Oticon Intent is a premium behind-the-ear prescription hearing aid released in 2024, priced at $4,898. With a SoundScore of 4.8/5 and an A grade, it ranks #3 among the 36 prescription hearing aids tested by HearAdvisor, placing it in the top 6% of its category. In our lab testing, the Intent delivers strong speech performance, scoring 1.10 points above the category average for speech in noise and 0.62 points above average for speech in quiet. Music streaming is a particular strength at 4.0/5, which is 1.36 points above the prescription hearing aid average—making it a solid choice for users who frequently stream audio from their phones. Feedback handling is excellent at 5.0/5, ensuring stable performance without whistling during everyday activities. The most notable limitation is own-voice comfort, which scores 1.3/5—a low result that falls 1.45 points below the category average. Users sensitive to how their own voice sounds while wearing hearing aids should be aware of this trade-off. The Intent includes rechargeable batteries, both iPhone and Android streaming, and hands-free calling capabilities. It has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024. This hearing aid is best suited for users prioritizing speech clarity in challenging listening environments and high-quality audio streaming, who can accept the own-voice characteristics. Within its premium price tier, competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Real (4.75/5) offer alternatives worth considering.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.